+682.5%
MRNA vs AMC
-98.0%
+780.5%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | AMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +4.3% | -6.6% | -2.4% |
| 7D | +5.5% | +2.3% | +3.2% | +5.3% |
| 30D | +158.7% | -0.7% | +159.5% | +159.0% |
| 3M | +182.1% | +35.2% | +146.9% | +177.5% |
| 6M | +151.8% | +124.6% | +27.2% | +141.5% |
| YTD | +393.6% | +69.9% | +323.7% | +378.1% |
| 1Y | +499.5% | -2.6% | +502.0% | +493.4% |
| 3Y | +29.3% | -79.8% | +109.1% | +31.9% |
| 5Y | -65.1% | -99.4% | +34.3% | -62.3% |
| All | +682.5% | -98.0% | +780.5% | +866.2% |
Cumulative growth
Daily Returns
Daily percentage return beside AMC.
Daily Out/Under-Performance
Portfolio return minus AMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded AMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling